Skip to Main Content
Skip Nav Destination

Online First / Early View

Online first articles are accepted and edited, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI.

Online First

Review Articles April 18 2024
Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors
Oncol Res Treat (2024) https://doi.org/10.1159/000538659
Research Articles April 5 2024
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience
Oncol Res Treat (2024) https://doi.org/10.1159/000538660
Research Articles April 5 2024
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial
Oncol Res Treat (2024) https://doi.org/10.1159/000537896
Letters April 4 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers
Oncol Res Treat (2024) https://doi.org/10.1159/000538662
Research Articles April 2 2024
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience
Oncol Res Treat (2024) https://doi.org/10.1159/000537988
Research Articles April 2 2024
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)
Oncol Res Treat (2024) https://doi.org/10.1159/000538143
Letters March 25 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies
Oncol Res Treat (2024) https://doi.org/10.1159/000538436
Research Articles March 15 2024
Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data
Oncol Res Treat (2024) https://doi.org/10.1159/000536652
Guidelines March 14 2024
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany
Oncol Res Treat (2024) https://doi.org/10.1159/000538171
Case Reports March 1 2024
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease
Oncol Res Treat (2024) https://doi.org/10.1159/000538104

Early View

Case Reports May 18 2024
Stereotactic Radiotherapy for penile metastasis: case report and systematic literature review
Oncol Res Treat (2024) https://doi.org/10.1159/000539275
Methods Article May 16 2024
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy of ponatinib versus imatinib in combination with low-intensity chemotherapy, to compare end of therapy with indication for SCT versus TKI, blinatumomab and chemotherapy in optimal responders and to evaluate blinatumomab in suboptimal responders (GMALL-EVOLVE)
Oncol Res Treat (2024) https://doi.org/10.1159/000539391
Research Articles May 7 2024
Evaluation of the Impact of Adaptive Progressive Supervised Resistance Training on Strength and Quality of Life in Patients with Breast Cancer During Chemotherapy: The VALESCO Study
Oncol Res Treat (2024) https://doi.org/10.1159/000539087
Research Articles May 7 2024
What do German Molecular Tumor Boards recommend in patients with PIK3CA mutated tumors? - Launch and first results from the German TEAM-D Transsectoral Molecular Tumor Board exchange platform Deutschland (TEAM-D) -
Oncol Res Treat (2024) https://doi.org/10.1159/000539217
Research Articles May 7 2024
Anaemia in hospitalized cancer patients: a retrospective study of two cohorts before and after the guideline update
Oncol Res Treat (2024) https://doi.org/10.1159/000539143
Case Reports April 18 2024
Metastases Affecting Cranial Nervous Structures in Male Breast Cancer: Two Case Reports
Oncol Res Treat (2024) https://doi.org/10.1159/000538933
Close Modal

or Create an Account

Close Modal
Close Modal